Targeting glycolysis: exploring a new frontier in glioblastoma therapy
L Yang, S Li, L Yu, J Leng, N Li - Frontiers in Immunology, 2025 - frontiersin.org
Glioblastoma (GBM) is a highly malignant primary central nervous system tumor that poses a
significant threat to patient survival due to its treatment resistance and rapid recurrence …
significant threat to patient survival due to its treatment resistance and rapid recurrence …